BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 46 filers reported holding BURNING ROCK BIOTECH LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $609,000 | -68.7% | 209,131 | 0.0% | 0.00% | -72.7% |
| Q1 2022 | $1,943,000 | -2.5% | 209,131 | 0.0% | 0.01% | +10.0% |
| Q4 2021 | $1,993,000 | -46.7% | 209,131 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $3,739,000 | -39.3% | 209,131 | 0.0% | 0.02% | -40.7% |
| Q2 2021 | $6,161,000 | +9.4% | 209,131 | 0.0% | 0.03% | +12.5% |
| Q1 2021 | $5,630,000 | +16.5% | 209,131 | 0.0% | 0.02% | +33.3% |
| Q4 2020 | $4,831,000 | -18.8% | 209,131 | -11.9% | 0.02% | -25.0% |
| Q3 2020 | $5,951,000 | -11.9% | 237,300 | -5.1% | 0.02% | -20.0% |
| Q2 2020 | $6,753,000 | – | 250,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |